Mitochondrial oxidant stress promotes alpha-synuclein aggregation and spreading in mice with mutated glucocerebrosidase
Pietro La VitolaiD, Éva M. SzegőiD, Rita Pinto‐CostaiD, Angela RollariD, Eugenia L. HarbachovaiD, Anthony H.V. SchapiraiD, Ayşe UlusoyiD, Donato A. Di MonteiD
Abstract
Mutations of the glucocerebrosidase-encoding gene, GBA1, are common risk factors for Parkinsons disease. Although only a minority of mutation-carrying individuals develops the disease, the mechanisms of neuronal vulnerability predisposing to pathology conversion remain largely unclear. In this study, heterozygous expression of a common glucocerebrosidase variant, namely the L444P mutation, was found to exacerbate -synuclein aggregation and spreading in a mouse model of Parkinson-like pathology targeting neurons of the medullary vagal system. These neurons are primary sites of -synuclein lesions in Parkinsons disease and were shown here to become more vulnerable to oxidative stress after L444P expression. Nitrative burden paralleled the enhanced formation of reactive oxygen species within vagal neurons expressing mutated glucocerebrosidase, as indicated by pronounced accumulation of nitrated -synuclein. A causal relationship linked mutation-induced oxidative stress to enhanced -synuclein pathology that could indeed be rescued by neuronal overexpression of the mitochondrial antioxidant enzyme superoxide dismutase 2. Further evidence supported a key involvement of mitochondria as sources of reactive oxygen species as well as targets of oxidative and nitrative damage within L444P-expressing neurons. Scavenging of oxygen species by superoxide dismutase 2 effectively counteracted deleterious nitrative reactions and prevented nitrated -synuclein burden. Taken together, these findings support the conclusion that enhanced vulnerability to mitochondrial oxidative stress conferred by glucocerebrosidase mutations should be considered an important mechanism predisposing to Parkinsons disease pathology, particularly in brain regions targeted by -synuclein aggregation and involved in -synuclein spreading.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 23
- FWCI
- 6.16
- Field percentile
- top 3%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuronopathic GBA1 L444P mutation accelerates glucosylsphingosine levels and formation of hippocampal alpha-synuclein inclusions
Casey L. Mahoney-Crane, Megha Viswanathan, … Laura A. Volpicelli‐Daley·Journal of NeurosciencePeer-reviewed·Dec 7, 2022
- Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation
C. Galvagnion, S. Cerri, … D. A. Di Monte·BrainPeer-reviewed·Apr 1, 2022
- Pronounced α-synuclein pathology in a seeding-based mouse model is not sufficient to induce mitochondrial respiration deficits in the striatum and amygdala
Johannes Burtscher, Jean‐Christophe Copin, … Hilal Ahmed Lashuel·eNeuroPeer-reviewed·Jun 2, 2020
- Antibody treatment targeting nitrated alpha-synuclein counteracts protein spreading pathology
Ayşe Ulusoy, Sarah Wright, … Donato A. Di Monte·bioRxiv·May 26, 2026
- A double-hit in vivo model of GBA1 viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration
Alexia Polissidis, Effrosyni Koronaiou, … Leonidas Stefanis·Neurobiology of DiseasePeer-reviewed·Jan 4, 2022
- Glycated alpha-synuclein assemblies cause distinct Parkinsons disease pathogenesis in mice
Akshaya Rajan, Anish Varghese, … Poonam Singh Thakur·ACS Chemical NeurosciencePeer-reviewed·Sep 12, 2025